Add 2 ml of bacteriostatic water to the 50 mg vial
At Skin SurgeMD, our formulations are built around clinically validated actives like GHK-Cu because your skin deserves more than marketing claims
We're looking for students and young professionals ready to turn innovative thinking into real-world impact
A longevity label is not clinical evidence Describing a product as a longevity peptide, telomere peptide or pineal bioregulator does not establish that it changes human ageing, healthspan or survival
,aspect=fit)
Cerebrolysin Research Protocols & Administration Dosing in Published Research Research investigations have employed diverse Cerebrolysin doses depending on species, condition, and route: Preclinical Studies: Rat stroke models: 2.5-7.5 ml/kg optimal range (0.8-7.5 ml/kg studied) Rat TBI models: 2.5 ml/kg identified as optimal dose Mouse neurodegenerative models: 5 ml/kg typical dose Administration timing: Usually 4 hours post-injury, daily for 10-21 days Human Clinical Trials: Acute stroke: 30-50 ml/day intravenously for 10-21 days Vascular dementia: 20-30 ml/day for 4-week cycles Alzheimers disease: 10-60 ml/day for 4-24 weeks Traumatic brain injury: 30-50 ml/day for 10-21 days Important: These dosing regimens are specific to the conditions and species studied and cannot be extrapolated across species or indications due to significant differences in pharmacokinetics, peptide metabolism, receptor expression patterns, and disease pathophysiology
